These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1634 related articles for article (PubMed ID: 30742114)

  • 1. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.
    Fang EF; Hou Y; Palikaras K; Adriaanse BA; Kerr JS; Yang B; Lautrup S; Hasan-Olive MM; Caponio D; Dan X; Rocktäschel P; Croteau DL; Akbari M; Greig NH; Fladby T; Nilsen H; Cader MZ; Mattson MP; Tavernarakis N; Bohr VA
    Nat Neurosci; 2019 Mar; 22(3):401-412. PubMed ID: 30742114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combination of
    Wang N; Wang H; Pan Q; Kang J; Liang Z; Zhang R
    Oxid Med Cell Longev; 2021; 2021():7158444. PubMed ID: 34887998
    [No Abstract]   [Full Text] [Related]  

  • 3. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Asarone improves learning and memory in Aβ
    Han Y; Wang N; Kang J; Fang Y
    Metab Brain Dis; 2020 Oct; 35(7):1109-1117. PubMed ID: 32556928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are mitophagy enhancers therapeutic targets for Alzheimer's disease?
    Pradeepkiran JA; Hindle A; Kshirsagar S; Reddy PH
    Biomed Pharmacother; 2022 May; 149():112918. PubMed ID: 35585708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P. edulis Extract Protects Against Amyloid-β Toxicity in Alzheimer's Disease Models Through Maintenance of Mitochondrial Homeostasis via the FOXO3/DAF-16 Pathway.
    Cao SQ; Aman Y; Fang EF; Tencomnao T
    Mol Neurobiol; 2022 Sep; 59(9):5612-5629. PubMed ID: 35739408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
    Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A
    Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of β2-adrenergic Receptor Ameliorates Amyloid-β-induced Mitophagy Defects and Tau Pathology in Mice.
    Chai GS; Wu JJ; Gong J; Zhou JL; Jiang ZQ; Yi HY; Gu Y; Huang HH; Yao ZY; Zhang YQ; Zhao P; Nie YJ
    Neuroscience; 2022 Nov; 505():34-50. PubMed ID: 36208707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease.
    Xiong X; Li S; Han TL; Zhou F; Zhang X; Tian M; Tang L; Li Y
    Exp Cell Res; 2020 Nov; 396(1):112266. PubMed ID: 32905804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta oligomers induce Parkin-mediated mitophagy by reducing Miro1.
    Kam MK; Lee DG; Kim B; Huh JW; Lee HJ; Park YH; Lee DS
    Biochem J; 2020 Dec; 477(23):4581-4597. PubMed ID: 33155636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitophagy pathways and Alzheimer's disease: From pathogenesis to treatment.
    Pan XJ; Misrani A; Tabassum S; Yang L
    Mitochondrion; 2021 Jul; 59():37-47. PubMed ID: 33872797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
    Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
    J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.